AI assistant
Sending…
Rapport Therapeutics, Inc. — Director's Dealing 2025
Mar 13, 2025
32034_dirs_2025-03-13_bd944ebd-7e7a-45de-9836-b05d1ad9b218.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Rapport Therapeutics, Inc. (RAPP)
CIK: 0002012593
Period of Report: 2025-03-12
Reporting Person: Ignelzi Troy A. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-03-12 | Common Stock | P | 9900 | $10.1 | Acquired | 9900 | Direct |
| 2025-03-13 | Common Stock | P | 100 | $9.98 | Acquired | 10000 | Direct |
More from Rapport Therapeutics, Inc.
Interim / Quarterly Report
2026
May 7
Earnings Release
2026
May 7
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Mar 30
Director's Dealing
2026
Feb 20
Director's Dealing
2026
Feb 20
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Feb 4